Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients

Leukemia. 2007 Mar;21(3):560-3. doi: 10.1038/sj.leu.2404536. Epub 2007 Jan 25.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / blood*
  • Female
  • Humans
  • Leukemia, Myeloid / blood*
  • Leukemia, Myeloid / diagnosis
  • Leukemia, Myeloid / mortality
  • Male
  • Neoplasm Proteins / blood*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Prognosis
  • Thymidine Kinase / blood*
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Thymidine Kinase
  • thymidine kinase 1